v2.4.1.9
SELECTED QUARTERLY RESULTS (UNAUDITED)
|
12 Months Ended |
|
Quarterly Financial Information Disclosure [Abstract] |
|
Quarterly Financial Information [Text Block] |
NOTE 21 - SELECTED QUARTERLY RESULTS (UNAUDITED)
The following table sets forth certain quarterly financial data for the periods indicated (in thousands, except per share data): | | | | | | | | | | | | | | | | | | Quarter Ended | | | | | | | | | Revenue | $ | 56,561 |
| | $ | 55,632 |
| | $ | 56,684 |
| | $ | 58,106 |
| Gross profit | 39,954 |
| | 38,147 |
| | 39,010 |
| | 42,741 |
| Income from operations | 8,185 |
| | 4,771 |
| | 4,996 |
| | 10,185 |
| Net income (1) | 5,966 |
| | 4,725 |
| | 5,550 |
| | 22,802 |
| Basic income per common share | 0.14 |
| | 0.11 |
| | 0.13 |
| | 0.55 |
| Diluted income per common share | 0.14 |
| | 0.11 |
| | 0.13 |
| | 0.54 |
| | | | | | | | | | Quarter Ended | | | | | | | | | Revenue | $ | 53,200 |
| | $ | 54,287 |
| | $ | 50,780 |
| | $ | 55,156 |
| Gross profit | 37,957 |
| | 38,057 |
| | 30,781 |
| | 36,831 |
| (Loss) income from operations (2), (3) | (1,552 | ) | | 5,041 |
| | (4,194 | ) | | 5,472 |
| Net (loss) income (2), (4) | (2,511 | ) | | 3,695 |
| | 796 |
| | 5,116 |
| Basic (loss) income per common share | (0.06 | ) | | 0.09 |
| | 0.02 |
| | 0.12 |
| Diluted (loss) income per common share | (0.06 | ) | | 0.09 |
| | 0.02 |
| | 0.12 |
|
(1) Net income in the fourth quarter of 2014 included an income tax benefit from the release of a portion of the valuation allowance on deferred tax assets in Canada and the recognition of a tax benefit related to intercompany profits on sales of assets for which the assets had not been disposed of as of December 31, 2014. See Note 13 – Income Taxes.
(2) Loss from operations and net loss in the first quarter of 2013 included a $7.0 million charge associated with the termination of the Company's prior molecular diagnostic distribution agreements.
(3) Loss from operations in the third quarter of 2013 included an expense for the full allowance against accounts receivable balances related to the bankruptcy of a customer totaling $3.9 million and restructuring charges of $4.3 million.
(4) Net income in the third quarter of 2013 included a $5.4 million gain on the sale of a minority interest in a private company and an adjustment of the fair value of the Company's contingent consideration liability to $0, which was established as part of the GenturaDx acquisition.
See Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations for further discussion. |
X |
- Definition
The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e765-108305
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e725-108305
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)-(j)
-URI http://asc.fasb.org/extlink&oid=35737889&loc=d3e1280-108306
Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section G
-Subsection 1
Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K (SK)
-Number 229
-Section 302
-Paragraph a
+ Details
Name: |
us-gaap_QuarterlyFinancialInformationTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
|